Get the Stockscreener App
11.67
0.43%
0.05
After Hours:
11.91
0.24
+2.06%
Medifast Inc stock is traded at $11.67, with a volume of 102.76K.
It is up +0.43% in the last 24 hours and down -3.07% over the past month.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
See More
Previous Close:
$11.62
Open:
$11.6
24h Volume:
102.76K
Relative Volume:
1.09
Market Cap:
$130.48M
Revenue:
$346.10M
Net Income/Loss:
$-20.02M
P/E Ratio:
-6.4022
EPS:
-1.8228
Net Cash Flow:
$-1.47M
1W Performance:
+1.39%
1M Performance:
-3.07%
6M Performance:
+9.78%
1Y Performance:
-11.99%
1-Day Range:
$11.51
$11.79
1-Week Range:
$11.38
$11.79
52-Week Range:
$9.22
$13.60
Medifast Inc Stock (MED) Company Profile
Name
Medifast Inc
Sector
Industry
Phone
(410) 581-8042
Address
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, HRB, FTDR, BFAM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
11.67 | 130.48M | 346.10M | -20.02M | -1.47M | -1.8228 |
ROL
Rollins Inc
|
32.15 | 15.47B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
77.83 | 10.61B | 4.33B | 535.79M | 486.05M | 3.79 |
HRB
H R Block Inc
|
43.83 | 5.37B | 3.91B | 736.10M | 760.88M | 5.6238 |
FTDR
Frontdoor Inc
|
77.83 | 5.36B | 2.12B | 260.00M | 385.00M | 3.5067 |
BFAM
Bright Horizons Family Solutions Inc
|
68.17 | 3.32B | 2.98B | 189.18M | 275.20M | 3.3254 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Upgrade | DA Davidson | Underperform → Neutral |
| Jun-05-24 | Downgrade | DA Davidson | Neutral → Underperform |
| Oct-13-23 | Initiated | Stephens | Equal-Weight |
| Nov-04-22 | Downgrade | DA Davidson | Buy → Neutral |
| Aug-04-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-25-21 | Upgrade | Jefferies | Hold → Buy |
| Nov-05-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jun-25-20 | Initiated | B. Riley FBR | Buy |
| Feb-27-20 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-19 | Downgrade | Dougherty & Company | Buy → Neutral |
| Jul-25-19 | Initiated | Jefferies | Buy |
| Nov-08-18 | Upgrade | Sidoti | Neutral → Buy |
| Mar-07-18 | Upgrade | Sidoti | Neutral → Buy |
| Sep-15-17 | Reiterated | DA Davidson | Buy |
| Aug-04-16 | Reiterated | Wunderlich | Hold |
| Jan-11-16 | Upgrade | Sidoti | Neutral → Buy |
| Nov-30-15 | Downgrade | Sidoti | Buy → Neutral |
| Oct-05-15 | Upgrade | Sidoti | Neutral → Buy |
| Nov-07-14 | Downgrade | Imperial Capital | Outperform → In-line |
| Aug-08-14 | Reiterated | Imperial Capital | Outperform |
| Apr-23-14 | Reiterated | Imperial Capital | Outperform |
| Sep-06-13 | Initiated | Imperial Capital | Outperform |
| Nov-06-12 | Reiterated | Northland Securities | Outperform |
| Jul-27-12 | Upgrade | Northland Securities | Market Perform → Outperform |
| Jul-09-12 | Downgrade | Standpoint Research | Buy → Hold |
| Jan-30-12 | Initiated | Standpoint Research | Buy |
View All
Medifast Inc Stock (MED) Latest News
Can Hormel Foods Keep Expanding Margins Despite Softer Retail Volumes? - Zacks Investment Research
Medifast presented Trilivy data and Medifast stock costs EUR 10.16 - AD HOC NEWS
Can Hormel Foods Tackle Input Costs With Pricing and Efficiency? - Zacks Investment Research
Medifast stock faces a smaller coach base after Q2 revenue beat - AD HOC NEWS
Can Medifast's Better Client Retention Support Revenue Stabilization? - Zacks Investment Research
Can Medifast's Better Client Retention Support Revenue Stabilization? - Yahoo Finance
Can Medifast's Better Client Retention Support Revenue Stabilization? - TradingView
Why Do You Keep Gaining Weight Back After Losing It - GlobeNewswire Inc.
Bank of America buys 87,118 Medifast shares for its portfolio - AD HOC NEWS
Medifast stock gets a new Bank of America stake - AD HOC NEWS
Bank of America Corp DE Purchases New Holdings in Medifast Inc $MED - marketbeat.com
Medifast director trust sells 19,089 shares. Medifast stock gains 1.67 percent - AD HOC NEWS
Don't Ignore The Insider Selling In Medifast - Simply Wall Street
Will Innovation and Digital Expansion Efforts Drive Clorox's Growth? - Zacks Investment Research
Here's Why Shares of BranchOut Food Surge 89% in a Year - Zacks Investment Research
Medifast (NYSE:MED) Stock: Insider Daniel Chard Sells 9,544 Shares - MarketBeat
Medifast (NYSE:MED) Stock: Insider Daniel Chard Sells 9,545 Shares - MarketBeat
Form 4 Medifast Inc For: 30 September By Investing.com - Investing.com South Africa
Medifast director Daniel Chard sells $226,288 in company shares - Investing.com
Form 4 Medifast Inc For: 30 September By Investing.com - Investing.com Canada
A preset trading plan covers Medifast (MED) director Chard's trust sales of 9,545 and 9,544 shares. - Stock Titan
Medifast (MED) officer Daniel Chard proposes selling 9,544 shares after a sale of 9,545 shares - Stock Titan
Hormel Foods Pricing Strategy: Can It Balance Value and Profitability? - Zacks Investment Research
Four stock-award lots make up Medifast (MED) officer Daniel Chard’s planned sale of 9,545 shares. - Stock Titan
Medifast, Inc. (MED) Stock Price, News, Quote & History - Yahoo! Finance Canada
Medifast, Inc. (MED) stock price, news, quote and history - Yahoo Finance Australia
Medifast (NYSE:MED) Stock Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Medifast stock gains as revenue reaches USD 76.38 million - AD HOC NEWS
Medifast stock holds near 52-week low as revenue outlook weakens - AD HOC NEWS
Medifast stock edges lower as guidance and analyst views diverge - AD HOC NEWS
MEDIFAST INC Q2 2026 Earnings: Loss Narrower Than Expected, Stock Edges HigherEarnings Manipulation Risk - careplusvn.com
BlackRock Inc. Makes New Investment in Medifast Inc $MED - MarketBeat
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Eastern Progress
Medifast (MED) Reports Q2 Loss, Beats Revenue Estimates - Eastern Progress
Medifast (NYSE:MED) Stock Crosses Above 200 Day Moving AverageTime to Sell? - marketbeat.com
Premiumization and Strong Brands Fuel Constellation Brands' Growth - Zacks Investment Research
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? - Eastern Progress
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? - Yahoo Finance
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report? - Yahoo Finance
MEDIFAST INC (MED) Peer Comparison – Compare with Others - valueresearchonline.com
Medifast Launches the Medifast Metabolic Health Institute - directsellingnews.com
MEDIFAST INC (MED) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Medifast director Kiai Parsa buys $529k in MED stock By Investing.com - Investing.com Nigeria
Medifast director Kiai Parsa buys $529k in MED stock By Investing.com - Investing.com Canada
Medifast (NYSE: MED) director adds 43K shares in open-market buy - stocktitan.net
MEDIFAST INC (MED) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Medifast (NYSE:MED) Director Purchases 43,150 Shares - marketbeat.com
After 45 years of research, Medifast launches a metabolic health institute - stocktitan.net
Medifast® Announces the Launch of the Medifast Metabolic Health Institute™ - Yahoo Finance
Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health? - Yahoo Finance
Medifast Inc Stock (MED) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medifast Inc Stock (MED) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chard Daniel R | Officer |
Sep 29 '26 |
Proposed Sale |
11.73 |
9,544 |
111,951 |
0 |
| Chard Daniel R | Director |
Sep 29 '26 |
Sale |
11.73 |
9,544 |
111,951 |
130,609 |
| Chard Daniel R | Officer |
Sep 28 '26 |
Proposed Sale |
11.98 |
9,545 |
114,338 |
0 |
| Kiai Parsa | Director |
Aug 26 '26 |
Buy |
12.26 |
43,150 |
529,157 |
707,492 |
| Kiai Parsa | Director |
Aug 24 '26 |
Buy |
12.00 |
4,329 |
51,946 |
665,517 |
| Kiai Parsa | Director |
Aug 20 '26 |
Buy |
11.60 |
43,150 |
500,700 |
661,306 |
| Kiai Parsa | Director |
Aug 19 '26 |
Buy |
11.66 |
29,337 |
341,999 |
619,331 |
| SCHLACKMAN SCOTT | Director |
May 11 '26 |
Buy |
12.53 |
2,500 |
31,325 |
30,549 |
| SCHLACKMAN SCOTT | Director |
May 08 '26 |
Buy |
12.65 |
2,500 |
31,625 |
28,049 |
| Chard Daniel R | Chairman & CEO |
Mar 20 '26 |
Buy |
10.11 |
17,678 |
178,725 |
17,678 |
2.09%
38.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):